Cardiac Resynchronization Therapy to Aid Ventricular Assist Device Explantation in Infants with Cardiomyopathy and

Anila A Chaudhary1, Chandra Srinivasan2, Katsuhide Maeda3

  • 1Division of Cardiology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA. Chaudharaa@chop.edu.

Pediatric Cardiology
|September 11, 2025
PubMed

Insights

Two infants with heart failure and left bundle branch block (LBBB) improved with a ventricular assist device (LVAD). Cardiac resynchronization therapy (CRT) enabled successful LVAD removal, highlighting CRT

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Infants with severe left ventricular (LV) dysfunction and left bundle branch block (LBBB) present complex clinical challenges.
  • Left ventricular assist devices (LVADs) offer mechanical support but may not fully resolve dyssynchrony caused by LBBB.

Purpose of the Study:

  • To evaluate the role of cardiac resynchronization therapy (CRT) in facilitating LVAD explantation in infants with LBBB.
  • To explore CRT as a strategy for managing persistent ventricular dyssynchrony post-LVAD support.

Main Methods:

  • Case report of two previously healthy infants with dilated cardiomyopathy and LBBB.
  • Initial management with Berlin Heart EXCOR LVAD and serial echocardiograms.
  • LVAD turn-down trials to assess native LV function and dyssynchrony.
  • Successful LVAD explantation with simultaneous epicardial lead placement for biventricular CRT.

Main Results:

  • Both infants demonstrated improved LV function during LVAD support but persistent septal dyskinesis due to LBBB.
  • Successful LVAD explantation was achieved in both patients after CRT implantation.
  • Post-explantation follow-up indicated sustained benefit from CRT in managing dyssynchrony.

Conclusions:

  • Cardiac resynchronization therapy (CRT) can be a viable strategy to aid in the successful explantation of ventricular assist devices in select pediatric patients with LBBB and echocardiographic evidence of dyssynchrony.
  • This approach may improve long-term outcomes by addressing the underlying electrical dyssynchrony that impedes native cardiac recovery after mechanical support.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
554
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472